| HPV testing | |
|
The demand for a large-scale HPV screening and typing of the female population is indeed recognized by
national and international European health institutions and several countries are going to introduce HPV DNA
testing into the cervical cancer screening programs. The use of HPV DNA testing can provide women the opportunity for early screening programmes and detection of the cause of the cervical lesions. The availability of high accuracy cheap tests will allow screening on a larger population, enhancing the cervix cancer prevention policies. Furthermore, these methods will indeed offer a cost-effective solution for the validation of the new vaccine against HPV (cheap tests reduce the vaccine validation costs), thus having a reduced economic load on the EC. Hospitex Diagnostics propose two solutions for HPV testing: The e-BRID system The NANO-MUBIOP Project | |
 |
 |
 |